Listed

Wave Life Sciences, Inc.

WVENasdaqCIK 1631574HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$13.2m, Q3 FY2026
Operating income−$66.0m, Q3 FY2026
Net income−$61.9m, Q3 FY2026
Wave Life Sciences, Inc., income statement, quarterly
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Revenue$m29.1Revenue, Q4 FY2023, three months to 2023-12-31$29.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure12.5Revenue, Q1 FY2024, three months to 2024-03-31$12.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0000950170-25-066404.Report this figure19.7Revenue, Q2 FY2024, three months to 2024-06-30$19.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0000950170-25-099884.Report this figurenot reportednot reported9.2Revenue, Q1 FY2025, three months to 2025-03-31$9.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure8.7Revenue, Q2 FY2025, three months to 2025-06-30$8.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure7.6Revenue, Q3 FY2025, three months to 2025-09-30$7.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure17.2Revenue, Q4 FY2025, three months to 2025-12-31$17.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure38.2Revenue, Q1 FY2026, three months to 2026-03-31$38.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure2.3Revenue, Q2 FY2026, three months to 2026-06-30$2.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure13.2Revenue, Q3 FY2026, three months to 2026-09-30$13.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure
Research and development$m34.1Research and development, Q4 FY2023, three months to 2023-12-31$34.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure33.4Research and development, Q1 FY2024, three months to 2024-03-31$33.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066404.Report this figure40.4Research and development, Q2 FY2024, three months to 2024-06-30$40.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-30, accession 0000950170-25-099884.Report this figure41.2Research and development, Q3 FY2024, three months to 2024-09-30$41.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-273288.Report this figure44.6Research and development, Q4 FY2024, three months to 2024-12-31$44.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure40.6Research and development, Q1 FY2025, three months to 2025-03-31$40.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure43.5Research and development, Q2 FY2025, three months to 2025-06-30$43.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure45.9Research and development, Q3 FY2025, three months to 2025-09-30$45.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure52.8Research and development, Q4 FY2025, three months to 2025-12-31$52.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure47.4Research and development, Q1 FY2026, three months to 2026-03-31$47.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure51.3Research and development, Q2 FY2026, three months to 2026-06-30$51.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure53.8Research and development, Q3 FY2026, three months to 2026-09-30$53.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure
Operating income$m(18.7)Operating income, Q4 FY2023, three months to 2023-12-31−$18.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure(34.5)Operating income, Q1 FY2024, three months to 2024-03-31−$34.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066404.Report this figure(35.0)Operating income, Q2 FY2024, three months to 2024-06-30−$35.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-30, accession 0000950170-25-099884.Report this figure(63.9)Operating income, Q3 FY2024, three months to 2024-09-30−$63.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273288.Report this figure23.0Operating income, Q4 FY2024, three months to 2024-12-31$23.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure(49.8)Operating income, Q1 FY2025, three months to 2025-03-31−$49.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure(52.8)Operating income, Q2 FY2025, three months to 2025-06-30−$52.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure(56.4)Operating income, Q3 FY2025, three months to 2025-09-30−$56.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure(56.5)Operating income, Q4 FY2025, three months to 2025-12-31−$56.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure(31.3)Operating income, Q1 FY2026, three months to 2026-03-31−$31.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure(73.8)Operating income, Q2 FY2026, three months to 2026-06-30−$73.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure(66.0)Operating income, Q3 FY2026, three months to 2026-09-30−$66.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure
Income tax$m0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0000950170-25-066404.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-30, accession 0000950170-25-099884.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001193125-25-273288.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure0.0Income tax, Q3 FY2026, three months to 2026-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure
Net income$m(16.3)Net income, Q4 FY2023, three months to 2023-12-31−$16.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure(31.6)Net income, Q1 FY2024, three months to 2024-03-31−$31.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273288.Report this figure(32.9)Net income, Q2 FY2024, three months to 2024-06-30−$32.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273288.Report this figure(61.8)Net income, Q3 FY2024, three months to 2024-09-30−$61.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-273288.Report this figure29.3Net income, Q4 FY2024, three months to 2024-12-31$29.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure(46.9)Net income, Q1 FY2025, three months to 2025-03-31−$46.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure(50.5)Net income, Q2 FY2025, three months to 2025-06-30−$50.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure(53.9)Net income, Q3 FY2025, three months to 2025-09-30−$53.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure(53.2)Net income, Q4 FY2025, three months to 2025-12-31−$53.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure(26.1)Net income, Q1 FY2026, three months to 2026-03-31−$26.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure(69.4)Net income, Q2 FY2026, three months to 2026-06-30−$69.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure(61.9)Net income, Q3 FY2026, three months to 2026-09-30−$61.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure
Diluted EPS$ per sharenot reported(0.24)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-066404.Report this figure(0.25)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-30, accession 0000950170-25-099884.Report this figure(0.47)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-273288.Report this figurenot reported(0.29)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure(0.31)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure(0.32)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figurenot reported(0.13)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure(0.34)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure(0.30)Diluted EPS, Q3 FY2026, three months to 2026-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure
Basic EPS$ per sharenot reported(0.24)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-066404.Report this figure(0.25)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-30, accession 0000950170-25-099884.Report this figure(0.47)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-273288.Report this figurenot reported(0.29)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure(0.31)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure(0.32)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figurenot reported(0.13)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure(0.34)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure(0.30)Basic EPS, Q3 FY2026, three months to 2026-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure

Balance sheet

Cash and equivalents$197.3m, Q3 FY2026
Shareholders' equity$401.9m, Q3 FY2026
Wave Life Sciences, Inc., balance sheet, quarterly
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Cash and equivalents$m200Cash and equivalents, FY2023, at 2023-12-31$200.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-04, accession 0000950170-25-031322.Report this figure181Cash and equivalents, Q1 FY2024, at 2024-03-31$180.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-10, accession 0000950170-24-057457.Report this figure154Cash and equivalents, Q2 FY2024, at 2024-06-30$154.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-093341.Report this figure311Cash and equivalents, Q3 FY2024, at 2024-09-30$310.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-124595.Report this figure302Cash and equivalents, FY2024, at 2024-12-31$302.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001193125-26-073472.Report this figure243Cash and equivalents, Q1 FY2025, at 2025-03-31$243.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066404.Report this figure208Cash and equivalents, Q2 FY2025, at 2025-06-30$208.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-30, accession 0000950170-25-099884.Report this figure196Cash and equivalents, Q3 FY2025, at 2025-09-30$196.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001193125-25-273288.Report this figure602Cash and equivalents, FY2025, at 2025-12-31$602.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure545Cash and equivalents, Q1 FY2026, at 2026-03-31$544.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure368Cash and equivalents, Q2 FY2026, at 2026-06-30$368.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure197Cash and equivalents, Q3 FY2026, at 2026-09-30$197.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure
Current assets$m235Current assets, FY2023, at 2023-12-31$235.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-04, accession 0000950170-25-031322.Report this figure197Current assets, Q1 FY2024, at 2024-03-31$196.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-10, accession 0000950170-24-057457.Report this figure172Current assets, Q2 FY2024, at 2024-06-30$172.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093341.Report this figure325Current assets, Q3 FY2024, at 2024-09-30$324.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-124595.Report this figure320Current assets, FY2024, at 2024-12-31$320.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001193125-26-073472.Report this figure258Current assets, Q1 FY2025, at 2025-03-31$258.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066404.Report this figure224Current assets, Q2 FY2025, at 2025-06-30$223.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-30, accession 0000950170-25-099884.Report this figure215Current assets, Q3 FY2025, at 2025-09-30$215.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-273288.Report this figure615Current assets, FY2025, at 2025-12-31$614.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure561Current assets, Q1 FY2026, at 2026-03-31$561.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure508Current assets, Q2 FY2026, at 2026-06-30$507.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure459Current assets, Q3 FY2026, at 2026-09-30$458.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure
Total assets$m275Total assets, FY2023, at 2023-12-31$274.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-04, accession 0000950170-25-031322.Report this figure235Total assets, Q1 FY2024, at 2024-03-31$235.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-10, accession 0000950170-24-057457.Report this figure209Total assets, Q2 FY2024, at 2024-06-30$208.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093341.Report this figure359Total assets, Q3 FY2024, at 2024-09-30$358.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-124595.Report this figure352Total assets, FY2024, at 2024-12-31$352.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001193125-26-073472.Report this figure288Total assets, Q1 FY2025, at 2025-03-31$288.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066404.Report this figure252Total assets, Q2 FY2025, at 2025-06-30$252.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-30, accession 0000950170-25-099884.Report this figure241Total assets, Q3 FY2025, at 2025-09-30$241.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001193125-25-273288.Report this figure638Total assets, FY2025, at 2025-12-31$638.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure584Total assets, Q1 FY2026, at 2026-03-31$583.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure558Total assets, Q2 FY2026, at 2026-06-30$558.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure508Total assets, Q3 FY2026, at 2026-09-30$507.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure
Current liabilities$m186Current liabilities, FY2023, at 2023-12-31$186.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-04, accession 0000950170-25-031322.Report this figure166Current liabilities, Q1 FY2024, at 2024-03-31$165.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-10, accession 0000950170-24-057457.Report this figure173Current liabilities, Q2 FY2024, at 2024-06-30$173.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093341.Report this figure171Current liabilities, Q3 FY2024, at 2024-09-30$170.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-124595.Report this figure111Current liabilities, FY2024, at 2024-12-31$111.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001193125-26-073472.Report this figure87.4Current liabilities, Q1 FY2025, at 2025-03-31$87.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066404.Report this figure87.4Current liabilities, Q2 FY2025, at 2025-06-30$87.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-30, accession 0000950170-25-099884.Report this figure85.9Current liabilities, Q3 FY2025, at 2025-09-30$85.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-273288.Report this figure95.1Current liabilities, FY2025, at 2025-12-31$95.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure49.8Current liabilities, Q1 FY2026, at 2026-03-31$49.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure50.8Current liabilities, Q2 FY2026, at 2026-06-30$50.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure54.8Current liabilities, Q3 FY2026, at 2026-09-30$54.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure
Total liabilities$m227Total liabilities, FY2023, at 2023-12-31$227.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-04, accession 0000950170-25-031322.Report this figure202Total liabilities, Q1 FY2024, at 2024-03-31$202.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-10, accession 0000950170-24-057457.Report this figure204Total liabilities, Q2 FY2024, at 2024-06-30$204.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093341.Report this figure209Total liabilities, Q3 FY2024, at 2024-09-30$209.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-124595.Report this figure135Total liabilities, FY2024, at 2024-12-31$134.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001193125-26-073472.Report this figure109Total liabilities, Q1 FY2025, at 2025-03-31$108.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066404.Report this figure105Total liabilities, Q2 FY2025, at 2025-06-30$105.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-30, accession 0000950170-25-099884.Report this figure109Total liabilities, Q3 FY2025, at 2025-09-30$109.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001193125-25-273288.Report this figure112Total liabilities, FY2025, at 2025-12-31$112.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure71.8Total liabilities, Q1 FY2026, at 2026-03-31$71.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure105Total liabilities, Q2 FY2026, at 2026-06-30$104.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure106Total liabilities, Q3 FY2026, at 2026-09-30$106.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure
Shareholders' equity$m39.6Shareholders' equity, FY2023, at 2023-12-31$39.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001193125-26-073472.Report this figure25.4Shareholders' equity, Q1 FY2024, at 2024-03-31$25.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273288.Report this figure(3.5)Shareholders' equity, Q2 FY2024, at 2024-06-30−$3.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273288.Report this figure142Shareholders' equity, Q3 FY2024, at 2024-09-30$141.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-273288.Report this figure210Shareholders' equity, FY2024, at 2024-12-31$209.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure172Shareholders' equity, Q1 FY2025, at 2025-03-31$171.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure139Shareholders' equity, Q2 FY2025, at 2025-06-30$139.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure125Shareholders' equity, Q3 FY2025, at 2025-09-30$124.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure518Shareholders' equity, FY2025, at 2025-12-31$518.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure512Shareholders' equity, Q1 FY2026, at 2026-03-31$511.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure454Shareholders' equity, Q2 FY2026, at 2026-06-30$453.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure402Shareholders' equity, Q3 FY2026, at 2026-09-30$401.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure

Cash flow

Operating cash flow−$60.1m, Q3 FY2026
Capital expenditure$15.0k, Q3 FY2026
Wave Life Sciences, Inc., cash flow, quarterly
Line itemUnitQ4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Operating cash flow$m(33.2)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$33.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure(33.4)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$33.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066404.Report this figure(27.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$27.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-30, accession 0000950170-25-099884. Derived: 6-month figure less the 3-month figure.Report this figure(46.5)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$46.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-273288. Derived: 9-month figure less the 6-month figure.Report this figure(43.6)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$43.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure(63.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$63.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure(46.0)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$46.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001193125-26-324949. Derived: 6-month figure less the 3-month figure.Report this figure(44.7)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$44.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-27, accession 0001193125-26-432714. Derived: 9-month figure less the 6-month figure.Report this figure(33.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$33.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure(59.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$59.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure(53.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$53.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001193125-26-324949. Derived: 6-month figure less the 3-month figure.Report this figure(60.1)Operating cash flow, Q3 FY2026, three months to 2026-09-30−$60.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-27, accession 0001193125-26-432714. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$m0.4Capital expenditure, Q4 FY2023, three months to 2023-12-31$356.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure0.4Capital expenditure, Q1 FY2024, three months to 2024-03-31$417.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-066404.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$52.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-30, accession 0000950170-25-099884. Derived: 6-month figure less the 3-month figure.Report this figure0.4Capital expenditure, Q3 FY2024, three months to 2024-09-30$383.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-273288. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$86.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2025, three months to 2025-03-31$165.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure0.3Capital expenditure, Q2 FY2025, three months to 2025-06-30$306.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001193125-26-324949. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$248.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-27, accession 0001193125-26-432714. Derived: 9-month figure less the 6-month figure.Report this figure(0.0)Capital expenditure, Q4 FY2025, three months to 2025-12-31−$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-073472. Derived: 12-month figure less the 9-month figure.Report this figure0.4Capital expenditure, Q1 FY2026, three months to 2026-03-31$438.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure0.9Capital expenditure, Q2 FY2026, three months to 2026-06-30$884.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001193125-26-324949. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2026, three months to 2026-09-30$15.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-27, accession 0001193125-26-432714. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)204.22m, Q3 FY2026
Wave Life Sciences, Inc., shares, quarterly
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Diluted shares (weighted)m shares102Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31102,056,712 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-10, accession 0000950170-24-057457.Report this figure105Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30105,462,414 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-093341.Report this figure107Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30106,975,231 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-124595.Report this figure129Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31129,271,678 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-066404.Report this figure130Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30129,527,003 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-30, accession 0000950170-25-099884.Report this figure133Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30132,563,467 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-273288.Report this figure163Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31162,572,026 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure164Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30163,987,640 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure168Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30167,739,208 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure200Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31200,167,869 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-28, accession 0001193125-26-183587.Report this figure204Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30204,008,712 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001193125-26-324949.Report this figure204Diluted shares (weighted), Q3 FY2026, three months to 2026-09-30204,222,255 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure

Shares outstanding: 197.23mShares outstanding, period not labelled, at 2026-10-21197,228,968 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-10-27, accession 0001193125-26-432714.Report this figure at Oct 21, 2026, from the cover of the 10-Q filed Oct 27, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 15:22 ET. Listed shows no prices and gives no investment advice.